MEG’s integrated digital tools revolutionise healthcare quality management, enabling healthcare providers to connect all the key components for the governance of care quality, compliance and patient safety in one central location. Through interoperable, user-friendly mobile and cloud-based technology, MEG aims to eliminate onerous paperwork for staff, allowing them to continue delivering quality patient care.

MEG’s innovative QMS system will centralise healthcare audit, incident, risk, patient experience and document management processes, replacing paper workflows with real-time reports and action plans for leadership and frontline staff. This transformation is expected to result in significant time and cost savings while providing comprehensive visibility into performance and risk management across the organisation.

MEG’s role in streamlining operations aligns with M42’s vision to employ pioneering technology-driven healthcare solutions to enhance patient care and well-being and provide the highest level of personalised precision and preventative health-tech solutions.

Ashish Koshy, M42’s Group Chief Operating Officer, said: “This partnership underscores our commitment to pushing the boundaries of healthcare technology for the benefit of our patients and the entire community we serve. Our strategy involves leveraging technology not as a mere tool but as a transformative force in co-designing the future of sustainable health. By harnessing MEG's solutions, we will continue to revolutionise the patient experience, enhance quality of care and empower our dedicated staff.”

MEG’s CEO, Kerrill Thornhill, shared his thoughts on the collaboration, saying, “We're delighted to partner with M42, a leading global health-tech company, and share our dedication to improving quality and patient safety. Our collaboration on best-in-class quality management systems will undoubtedly lead to better patient outcomes and drive process improvements across the organisation.”

In addition to this landmark contract, MEG is gearing up to elevate healthcare technology in 2024 with a comprehensive series of platform enhancements. These will include advanced analytics capabilities, state-of-the-art action planning tools, and enhanced hospital system integration capabilities. These advancements underscore MEG's commitment to continual improvement in healthcare quality, patient safety, and compliance technology, solidifying its position as a leader in healthcare innovation.

The official signing of this collaboration took place at Arab Health on 31 January at the M42 stand.

For further information regarding MEG and its services, please visit https://www.megit.com

ABOUT MEG

MEG is a digital quality management system for healthcare. Its suite of configurable mobile and cloud-based tools enables providers to engage staff in quality improvement, patient safety and manage compliance with accreditation or regulatory standards.

The easy-to-use modules can be used on any device by frontline workers to collect data from all over an organisation. Capture incidents, audits, risk assessments, and access information anytime right at the point of care.

Management can collate, analyse and act upon real-time information and metrics across multiple sites, consolidating data into a centralised platform.

MEG is currently in operation in more than 20 countries across Europe, the Middle East, Australasia and Latin America with multi-lingual support.

ABOUT M42

M42 is a first-of-its-kind global tech-enabled health powerhouse committed to the sustainable future of health. The Abu Dhabi-headquartered company is transforming lives through innovative clinical solutions that are solving the world’s most critical health and diagnostic challenges. By harnessing innovative solutions and unique medical and data-centric technologies, including genomics and AI, M42 is delivering the highest level of personalized, precise, and preventative care to impactfully disrupt the global healthcare ecosystem.

M42 has over 20,000 employees and more than 450 facilities in 26 countries. Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 combines unique medical and data-centric technologies with state-of-the-art facilities to deliver world-class care.

M42 owns and manages an integrated portfolio of health-tech and healthcare service providers including Diaverum, G42 Healthcare, Cleveland Clinic Abu Dhabi, Imperial College London Diabetes Centre and Moorfields Eye Hospital Abu Dhabi, among others.